> top > docs > PubMed:7811247 > annotations

PubMed:7811247 JSONTXT

Annnotations TAB JSON ListView MergeView

TEST-DiseaseOrPhenotypicFeature

Id Subject Object Predicate Lexical cue #label
T1 9-29 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy D000326
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD D000326
T3 61-64 DiseaseOrPhenotypicFeature denotes ALD D000326
T4 152-172 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy D000326
T5 174-177 DiseaseOrPhenotypicFeature denotes ALD D000326
T6 215-218 DiseaseOrPhenotypicFeature denotes ALD D000326
T7 324-327 DiseaseOrPhenotypicFeature denotes ALD D000326
T8 527-530 DiseaseOrPhenotypicFeature denotes ALD D000326
T9 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy D000326
T10 745-748 DiseaseOrPhenotypicFeature denotes ALD D000326

TEST-ChemicalEntity

Id Subject Object Predicate Lexical cue ID:
T1 345-353 ChemicalEntity denotes cytosine D003596|http://purl.obolibrary.org/obo/CHEBI_16040
T3 357-364 ChemicalEntity denotes guanine D006147|http://purl.obolibrary.org/obo/CHEBI_16235
T5 440-447 ChemicalEntity denotes proline http://purl.obolibrary.org/obo/CHEBI_26271|http://purl.obolibrary.org/obo/CHEBI_17203
T7 455-463 ChemicalEntity denotes arginine http://purl.obolibrary.org/obo/CHEBI_32696|http://purl.obolibrary.org/obo/CHEBI_29016|http://purl.obolibrary.org/obo/CHEBI_16467
T10 633-655 ChemicalEntity denotes long chain fatty acids http://purl.obolibrary.org/obo/CHEBI_15904

TEST-OrganismTaxon

Id Subject Object Predicate Lexical cue
T1 191-198 OrganismTaxon denotes patient
T2 494-501 OrganismTaxon denotes patient
T3 749-757 OrganismTaxon denotes patients

Test-GeneOrGeneProduct

Id Subject Object Predicate Lexical cue
T1 633-655 GeneOrGeneProduct denotes long chain fatty acids

Test-merged-2

Id Subject Object Predicate Lexical cue #label ID:
T14590 345-353 ChemicalEntity denotes cytosine D003596|http://purl.obolibrary.org/obo/CHEBI_16040
T8763 357-364 ChemicalEntity denotes guanine D006147|http://purl.obolibrary.org/obo/CHEBI_16235
T70538 440-447 ChemicalEntity denotes proline http://purl.obolibrary.org/obo/CHEBI_26271|http://purl.obolibrary.org/obo/CHEBI_17203
T30708 455-463 ChemicalEntity denotes arginine http://purl.obolibrary.org/obo/CHEBI_32696|http://purl.obolibrary.org/obo/CHEBI_29016|http://purl.obolibrary.org/obo/CHEBI_16467
T25434 633-655 ChemicalEntity denotes long chain fatty acids http://purl.obolibrary.org/obo/CHEBI_15904
T88141 633-655 GeneOrGeneProduct denotes long chain fatty acids
T45995 191-198 OrganismTaxon denotes patient
T29740 494-501 OrganismTaxon denotes patient
T18858 749-757 OrganismTaxon denotes patients
T1 9-29 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy D000326
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD D000326
T3 61-64 DiseaseOrPhenotypicFeature denotes ALD D000326
T4 152-172 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy D000326
T5 174-177 DiseaseOrPhenotypicFeature denotes ALD D000326
T6 215-218 DiseaseOrPhenotypicFeature denotes ALD D000326
T7 324-327 DiseaseOrPhenotypicFeature denotes ALD D000326
T8 527-530 DiseaseOrPhenotypicFeature denotes ALD D000326
T9 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy D000326
T10 745-748 DiseaseOrPhenotypicFeature denotes ALD D000326

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-134 Sentence denotes X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes.
TextSentencer_T2 135-277 Sentence denotes Fragments of the adrenoleukodystrophy (ALD) cDNA from a patient with adolescent ALD were amplified by polymerase chain reaction and subcloned.
TextSentencer_T3 278-464 Sentence denotes Bidirectional sequencing of the entire coding ALD gene disclosed a cytosine to guanine transversion at nucleotide 1451 in exon five, resulting in substitution of proline 484 by arginine.
TextSentencer_T4 465-782 Sentence denotes Five of nine siblings of the patient, comprising two cerebral ALD, one adrenomyeloneuropathy, one Addison only as well as the symptomatic mother (all accumulating very long chain fatty acids) carried this mutation, which was not found in the unaffected persons, in five unrelated ALD patients, and in twenty controls.
TextSentencer_T5 783-984 Sentence denotes We propose that this missense mutation generated the disease per se as well as the metabolic defect; the different phenotypes, however, must have originated by means of additional pathogenetic factors.
T1 0-134 Sentence denotes X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes.
T2 135-277 Sentence denotes Fragments of the adrenoleukodystrophy (ALD) cDNA from a patient with adolescent ALD were amplified by polymerase chain reaction and subcloned.
T3 278-464 Sentence denotes Bidirectional sequencing of the entire coding ALD gene disclosed a cytosine to guanine transversion at nucleotide 1451 in exon five, resulting in substitution of proline 484 by arginine.
T4 465-782 Sentence denotes Five of nine siblings of the patient, comprising two cerebral ALD, one adrenomyeloneuropathy, one Addison only as well as the symptomatic mother (all accumulating very long chain fatty acids) carried this mutation, which was not found in the unaffected persons, in five unrelated ALD patients, and in twenty controls.
T5 783-984 Sentence denotes We propose that this missense mutation generated the disease per se as well as the metabolic defect; the different phenotypes, however, must have originated by means of additional pathogenetic factors.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 61-64 gene:215 denotes ALD
T1 0-29 disease:C0162309 denotes X-linked adrenoleukodystrophy
T2 61-64 gene:215 denotes ALD
T3 31-34 disease:C0162309 denotes ALD
R1 T0 T1 associated_with ALD,X-linked adrenoleukodystrophy
R2 T2 T3 associated_with ALD,ALD

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
7811247-0#61#64#gene215 61-64 gene215 denotes ALD
7811247-0#0#29#diseaseC0162309 0-29 diseaseC0162309 denotes X-linked adrenoleukodystrophy
7811247-0#31#34#diseaseC0162309 31-34 diseaseC0162309 denotes ALD
61#64#gene2150#29#diseaseC0162309 7811247-0#61#64#gene215 7811247-0#0#29#diseaseC0162309 associated_with ALD,X-linked adrenoleukodystrophy
61#64#gene21531#34#diseaseC0162309 7811247-0#61#64#gene215 7811247-0#31#34#diseaseC0162309 associated_with ALD,ALD

PubCasesORDO

Id Subject Object Predicate Lexical cue
TI1 0-29 ORDO:43 denotes X-linked adrenoleukodystrophy
TI2 31-34 ORDO:43 denotes ALD
AB1 174-177 ORDO:43 denotes ALD
TI3 61-64 ORDO:43 denotes ALD
AB2 215-218 ORDO:43 denotes ALD
AB3 324-327 ORDO:43 denotes ALD
AB4 527-530 ORDO:43 denotes ALD
AB5 745-748 ORDO:43 denotes ALD

NCBIDiseaseCorpus

Id Subject Object Predicate Lexical cue
T1 0-29 SpecificDisease:D000326 denotes X-linked adrenoleukodystrophy
T2 31-34 SpecificDisease:D000326 denotes ALD
T3 61-64 Modifier:D000326 denotes ALD
T4 152-172 Modifier:D000326 denotes adrenoleukodystrophy
T5 174-177 Modifier:D000326 denotes ALD
T6 204-218 SpecificDisease:D000326 denotes adolescent ALD
T7 324-327 Modifier:D000326 denotes ALD
T8 518-530 SpecificDisease:D000326 denotes cerebral ALD
T9 536-557 SpecificDisease:D000326 denotes adrenomyeloneuropathy
T10 563-575 SpecificDisease:D000224 denotes Addison only
T11 745-748 Modifier:D000326 denotes ALD

biored-valid-deepseek-nr-ng

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 152-183 GeneOrGeneProduct denotes adrenoleukodystrophy (ALD) cDNA
T4 324-332 GeneOrGeneProduct denotes ALD gene
T5 345-353 ChemicalEntity denotes cytosine
T6 357-364 ChemicalEntity denotes guanine
T7 440-447 ChemicalEntity denotes proline
T8 455-463 ChemicalEntity denotes arginine
T9 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T10 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T11 563-575 DiseaseOrPhenotypicFeature denotes Addison only
T12 628-655 ChemicalEntity denotes very long chain fatty acids
T13 745-757 DiseaseOrPhenotypicFeature denotes ALD patients

biored-valid

Id Subject Object Predicate Lexical cue
T1 0-29 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD
T3 61-64 GeneOrGeneProduct denotes ALD
T4 152-172 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy
T5 174-177 DiseaseOrPhenotypicFeature denotes ALD
T6 191-198 OrganismTaxon denotes patient
T7 215-218 DiseaseOrPhenotypicFeature denotes ALD
T8 324-327 GeneOrGeneProduct denotes ALD
T9 345-396 SequenceVariant denotes cytosine to guanine transversion at nucleotide 1451
T10 440-463 SequenceVariant denotes proline 484 by arginine
T11 494-501 OrganismTaxon denotes patient
T12 527-530 DiseaseOrPhenotypicFeature denotes ALD
T13 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T14 563-570 DiseaseOrPhenotypicFeature denotes Addison
T15 633-655 ChemicalEntity denotes long chain fatty acids
T16 745-748 DiseaseOrPhenotypicFeature denotes ALD
T17 749-757 OrganismTaxon denotes patients

biored-valid-deepseek-nr-g

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 152-178 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy (ALD)
T4 179-183 GeneOrGeneProduct denotes cDNA
T5 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T6 392-396 SequenceVariant denotes 1451
T7 400-409 SequenceVariant denotes exon five
T8 440-447 SequenceVariant denotes proline
T9 448-451 SequenceVariant denotes 484
T10 455-463 SequenceVariant denotes arginine
T11 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T12 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T13 563-575 DiseaseOrPhenotypicFeature denotes Addison only
T14 628-655 ChemicalEntity denotes very long chain fatty acids
T15 804-821 SequenceVariant denotes missense mutation

biored-valid-deepseek-r-ng

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T4 345-409 SequenceVariant denotes cytosine to guanine transversion at nucleotide 1451 in exon five
T5 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T6 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T7 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T8 563-575 DiseaseOrPhenotypicFeature denotes Addison only
T9 628-655 ChemicalEntity denotes very long chain fatty acids
T10 804-821 SequenceVariant denotes missense mutation

biored-valid-deepseek-r-g

Id Subject Object Predicate Lexical cue
T1 0-29 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD
T3 61-69 GeneOrGeneProduct denotes ALD gene
T4 152-172 GeneOrGeneProduct denotes adrenoleukodystrophy
T5 174-177 GeneOrGeneProduct denotes ALD
T6 179-183 GeneOrGeneProduct denotes cDNA
T7 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T8 324-332 GeneOrGeneProduct denotes ALD gene
T9 345-377 SequenceVariant denotes cytosine to guanine transversion
T10 440-463 SequenceVariant denotes proline 484 by arginine
T11 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T12 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T13 563-570 DiseaseOrPhenotypicFeature denotes Addison
T14 628-655 ChemicalEntity denotes very long chain fatty acids
T15 804-821 SequenceVariant denotes missense mutation

biored-valid-gemini-nr-ng

Id Subject Object Predicate Lexical cue
T1 0-29 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD
T3 61-69 GeneOrGeneProduct denotes ALD gene
T4 152-172 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy
T5 174-177 DiseaseOrPhenotypicFeature denotes ALD
T6 179-183 GeneOrGeneProduct denotes cDNA
T7 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T8 324-332 GeneOrGeneProduct denotes ALD gene
T9 345-353 ChemicalEntity denotes cytosine
T10 357-364 ChemicalEntity denotes guanine
T11 365-377 SequenceVariant denotes transversion
T12 440-447 ChemicalEntity denotes proline
T13 455-463 ChemicalEntity denotes arginine
T14 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T15 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T16 563-575 DiseaseOrPhenotypicFeature denotes Addison only
T17 628-655 ChemicalEntity denotes very long chain fatty acids
T18 804-821 SequenceVariant denotes missense mutation
T19 836-843 DiseaseOrPhenotypicFeature denotes disease
T20 866-882 DiseaseOrPhenotypicFeature denotes metabolic defect

biored-valid-gemini-r-g

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 152-183 GeneOrGeneProduct denotes adrenoleukodystrophy (ALD) cDNA
T4 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T5 324-332 GeneOrGeneProduct denotes ALD gene
T6 345-396 SequenceVariant denotes cytosine to guanine transversion at nucleotide 1451
T7 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T8 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T9 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T10 563-575 DiseaseOrPhenotypicFeature denotes Addison only
T11 628-655 ChemicalEntity denotes very long chain fatty acids
T12 745-757 DiseaseOrPhenotypicFeature denotes ALD patients
T13 804-821 SequenceVariant denotes missense mutation
T14 836-843 DiseaseOrPhenotypicFeature denotes disease
T15 866-882 DiseaseOrPhenotypicFeature denotes metabolic defect

biored-valid-gemini-r-ng

Id Subject Object Predicate Lexical cue
T1 0-29 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD
T3 45-53 SequenceVariant denotes mutation
T4 61-69 GeneOrGeneProduct denotes ALD gene
T5 123-133 DiseaseOrPhenotypicFeature denotes phenotypes
T6 152-172 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy
T7 174-177 DiseaseOrPhenotypicFeature denotes ALD
T8 179-183 ChemicalEntity denotes cDNA
T9 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T10 324-332 GeneOrGeneProduct denotes ALD gene
T11 345-353 ChemicalEntity denotes cytosine
T12 357-364 ChemicalEntity denotes guanine
T13 365-377 SequenceVariant denotes transversion
T14 424-436 SequenceVariant denotes substitution
T15 440-447 ChemicalEntity denotes proline
T16 455-463 ChemicalEntity denotes arginine
T17 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T18 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T19 563-570 DiseaseOrPhenotypicFeature denotes Addison
T20 591-602 DiseaseOrPhenotypicFeature denotes symptomatic
T21 628-655 ChemicalEntity denotes very long chain fatty acids
T22 670-678 SequenceVariant denotes mutation
T23 745-748 DiseaseOrPhenotypicFeature denotes ALD
T24 804-821 SequenceVariant denotes missense mutation
T25 836-843 DiseaseOrPhenotypicFeature denotes disease
T26 866-882 DiseaseOrPhenotypicFeature denotes metabolic defect
T27 898-908 DiseaseOrPhenotypicFeature denotes phenotypes

biored-valid-gpt-nr-ng

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 152-178 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy (ALD)
T4 179-183 ChemicalEntity denotes cDNA
T5 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T6 324-332 GeneOrGeneProduct denotes ALD gene
T7 345-353 ChemicalEntity denotes cytosine
T8 357-364 ChemicalEntity denotes guanine
T9 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T10 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T11 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T12 563-570 DiseaseOrPhenotypicFeature denotes Addison
T13 628-655 ChemicalEntity denotes very long chain fatty acids
T14 745-748 DiseaseOrPhenotypicFeature denotes ALD
T15 804-821 SequenceVariant denotes missense mutation
T16 866-882 DiseaseOrPhenotypicFeature denotes metabolic defect

biored-valid-gpt-nr-g

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 152-183 GeneOrGeneProduct denotes adrenoleukodystrophy (ALD) cDNA
T4 324-332 GeneOrGeneProduct denotes ALD gene
T5 345-409 SequenceVariant denotes cytosine to guanine transversion at nucleotide 1451 in exon five
T6 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T7 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T8 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T9 563-570 DiseaseOrPhenotypicFeature denotes Addison
T10 628-655 ChemicalEntity denotes very long chain fatty acids
T11 745-748 DiseaseOrPhenotypicFeature denotes ALD
T12 804-821 SequenceVariant denotes missense mutation

biored-valid-gpt-r-ng

Id Subject Object Predicate Lexical cue
T1 0-29 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD
T3 39-53 SequenceVariant denotes novel mutation
T4 61-69 GeneOrGeneProduct denotes ALD gene
T5 152-172 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy
T6 174-177 DiseaseOrPhenotypicFeature denotes ALD
T7 179-183 ChemicalEntity denotes cDNA
T8 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T9 324-332 GeneOrGeneProduct denotes ALD gene
T10 345-353 ChemicalEntity denotes cytosine
T11 357-364 ChemicalEntity denotes guanine
T12 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T13 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T14 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T15 563-570 DiseaseOrPhenotypicFeature denotes Addison
T16 628-655 ChemicalEntity denotes very long chain fatty acids
T17 665-678 SequenceVariant denotes this mutation
T18 745-748 DiseaseOrPhenotypicFeature denotes ALD
T19 804-821 SequenceVariant denotes missense mutation
T20 866-882 DiseaseOrPhenotypicFeature denotes metabolic defect

biored-valid-gpt-r-g

Id Subject Object Predicate Lexical cue
T1 0-29 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD
T3 45-53 SequenceVariant denotes mutation
T4 61-69 GeneOrGeneProduct denotes ALD gene
T5 152-183 GeneOrGeneProduct denotes adrenoleukodystrophy (ALD) cDNA
T6 324-332 GeneOrGeneProduct denotes ALD gene
T7 345-396 SequenceVariant denotes cytosine to guanine transversion at nucleotide 1451
T8 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T9 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T10 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T11 563-570 DiseaseOrPhenotypicFeature denotes Addison
T12 628-655 ChemicalEntity denotes very long chain fatty acids
T13 670-678 SequenceVariant denotes mutation
T14 745-748 DiseaseOrPhenotypicFeature denotes ALD
T15 804-821 SequenceVariant denotes missense mutation

biored-valid-gemini-nr-g

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 152-178 DiseaseOrPhenotypicFeature denotes adrenoleukodystrophy (ALD)
T4 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T5 324-332 GeneOrGeneProduct denotes ALD gene
T6 345-396 SequenceVariant denotes cytosine to guanine transversion at nucleotide 1451
T7 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T8 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T9 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T10 563-575 DiseaseOrPhenotypicFeature denotes Addison only
T11 804-821 SequenceVariant denotes missense mutation

biored-valid-gpt-r-m

Id Subject Object Predicate Lexical cue
T1 0-29 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy
T2 31-34 DiseaseOrPhenotypicFeature denotes ALD
T3 45-53 SequenceVariant denotes mutation
T4 152-178 GeneOrGeneProduct denotes adrenoleukodystrophy (ALD)
T5 191-198 OrganismTaxon denotes patient
T6 324-327 GeneOrGeneProduct denotes ALD
T7 345-353 ChemicalEntity denotes cytosine
T8 357-364 ChemicalEntity denotes guanine
T9 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T10 494-501 OrganismTaxon denotes patient
T11 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T12 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T13 563-570 DiseaseOrPhenotypicFeature denotes Addison
T14 628-655 ChemicalEntity denotes very long chain fatty acids
T15 670-678 SequenceVariant denotes mutation
T16 745-748 DiseaseOrPhenotypicFeature denotes ALD
T17 749-757 OrganismTaxon denotes patients
T18 773-781 OrganismTaxon denotes controls
T19 804-821 SequenceVariant denotes missense mutation

biored-valid-gemini-r-m

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 152-183 GeneOrGeneProduct denotes adrenoleukodystrophy (ALD) cDNA
T4 191-198 OrganismTaxon denotes patient
T5 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T6 324-332 GeneOrGeneProduct denotes ALD gene
T7 345-377 SequenceVariant denotes cytosine to guanine transversion
T8 424-463 SequenceVariant denotes substitution of proline 484 by arginine
T9 494-501 OrganismTaxon denotes patient
T10 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T11 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T12 563-575 DiseaseOrPhenotypicFeature denotes Addison only
T13 603-609 OrganismTaxon denotes mother
T14 628-655 ChemicalEntity denotes very long chain fatty acids
T15 707-725 OrganismTaxon denotes unaffected persons
T16 745-757 DiseaseOrPhenotypicFeature denotes ALD patients
T17 773-781 OrganismTaxon denotes controls
T18 804-821 SequenceVariant denotes missense mutation
T19 866-882 DiseaseOrPhenotypicFeature denotes metabolic defect

biored-valid-deepseek-r-m

Id Subject Object Predicate Lexical cue
T1 0-35 DiseaseOrPhenotypicFeature denotes X-linked adrenoleukodystrophy (ALD)
T2 61-69 GeneOrGeneProduct denotes ALD gene
T3 152-183 GeneOrGeneProduct denotes adrenoleukodystrophy (ALD) cDNA
T4 204-218 DiseaseOrPhenotypicFeature denotes adolescent ALD
T5 324-332 GeneOrGeneProduct denotes ALD gene
T6 345-377 SequenceVariant denotes cytosine to guanine transversion
T7 440-463 SequenceVariant denotes proline 484 by arginine
T8 518-530 DiseaseOrPhenotypicFeature denotes cerebral ALD
T9 536-557 DiseaseOrPhenotypicFeature denotes adrenomyeloneuropathy
T10 563-570 DiseaseOrPhenotypicFeature denotes Addison
T11 628-655 ChemicalEntity denotes very long chain fatty acids
T12 745-748 DiseaseOrPhenotypicFeature denotes ALD
T13 804-821 SequenceVariant denotes missense mutation

NCBI-Disease-Train

Id Subject Object Predicate Lexical cue database_id
T243 0-29 SpecificDisease denotes X-linked adrenoleukodystrophy D000326
T244 31-34 SpecificDisease denotes ALD D000326
T245 61-64 Modifier denotes ALD D000326
T246 152-172 Modifier denotes adrenoleukodystrophy D000326
T247 174-177 Modifier denotes ALD D000326
T248 204-218 SpecificDisease denotes adolescent ALD D000326
T249 324-327 Modifier denotes ALD D000326
T250 518-530 SpecificDisease denotes cerebral ALD D000326
T251 536-557 SpecificDisease denotes adrenomyeloneuropathy D000326
T252 563-575 SpecificDisease denotes Addison only D000224
T253 745-748 Modifier denotes ALD D000326

NCBI-Disease-Corpus-All

Id Subject Object Predicate Lexical cue database_id
T243 0-29 SpecificDisease denotes X-linked adrenoleukodystrophy D000326
T244 31-34 SpecificDisease denotes ALD D000326
T245 61-64 Modifier denotes ALD D000326
T246 152-172 Modifier denotes adrenoleukodystrophy D000326
T247 174-177 Modifier denotes ALD D000326
T248 204-218 SpecificDisease denotes adolescent ALD D000326
T249 324-327 Modifier denotes ALD D000326
T250 518-530 SpecificDisease denotes cerebral ALD D000326
T251 536-557 SpecificDisease denotes adrenomyeloneuropathy D000326
T252 563-575 SpecificDisease denotes Addison only D000224
T253 745-748 Modifier denotes ALD D000326

NCBI-Disease-Corpus-2stage-All

Id Subject Object Predicate Lexical cue
T1 9-29 SpecificDisease denotes adrenoleukodystrophy
T2 31-34 SpecificDisease denotes ALD
T3 61-64 Modifier denotes ALD
T4 152-172 SpecificDisease denotes adrenoleukodystrophy
T5 174-177 SpecificDisease denotes ALD
T6 215-218 SpecificDisease denotes ALD
T7 324-327 Modifier denotes ALD
T8 527-530 SpecificDisease denotes ALD
T9 536-557 SpecificDisease denotes adrenomyeloneuropathy
T10 563-570 SpecificDisease denotes Addison
T11 745-748 SpecificDisease denotes ALD

NCBI-Disease-Corpus-rezarta-All

Id Subject Object Predicate Lexical cue
T1 9-29 SpecificDisease denotes adrenoleukodystrophy
T2 31-34 SpecificDisease denotes ALD
T3 61-64 Modifier denotes ALD
T4 152-172 SpecificDisease denotes adrenoleukodystrophy
T5 174-177 SpecificDisease denotes ALD
T6 215-218 SpecificDisease denotes ALD
T7 324-327 Modifier denotes ALD
T8 527-530 SpecificDisease denotes ALD
T9 536-557 SpecificDisease denotes adrenomyeloneuropathy
T10 563-570 SpecificDisease denotes Addison
T11 745-748 SpecificDisease denotes ALD

NCBI-Disease-Corpus-4oGuideline-All

Id Subject Object Predicate Lexical cue
T1 9-29 SpecificDisease denotes adrenoleukodystrophy
T2 152-172 SpecificDisease denotes adrenoleukodystrophy
T3 215-218 SpecificDisease denotes ALD
T4 518-530 SpecificDisease denotes cerebral ALD
T5 536-557 SpecificDisease denotes adrenomyeloneuropathy
T6 563-570 SpecificDisease denotes Addison
T7 745-748 SpecificDisease denotes ALD
T8 836-843 SpecificDisease denotes disease

NCBI-Disease-Corpus-Simple-All

Id Subject Object Predicate Lexical cue
T1 0-35 SpecificDisease denotes X-linked adrenoleukodystrophy (ALD)
T2 61-64 SpecificDisease denotes ALD
T3 152-178 SpecificDisease denotes adrenoleukodystrophy (ALD)
T4 215-218 SpecificDisease denotes ALD
T5 324-327 SpecificDisease denotes ALD
T6 518-530 DiseaseClass denotes cerebral ALD
T7 536-557 SpecificDisease denotes adrenomyeloneuropathy
T8 563-570 SpecificDisease denotes Addison
T9 745-748 SpecificDisease denotes ALD